The iPACE-CVD Program will explore the impact of an innovative digital health technology, Care4Today® Connect, on clinical outcomes, disease management, and medication adherence for patients with cardiovascular disease.
This program will be conducted in two parts:
1. Optimization
2. Clinical outcome evaluation
DISCLAIMER: Individuals depicted are models, for illustrative purposes only.
Goals
The first part of the program is focused on optimization and is a prospective, single arm, multi-center, non-interventional study. The Optimization Study will be conducted using the Care4Today® CAD-PAD mobile app and aims to collect information on app usefulness and patient engagement.
The Optimization Study is only being conducted in the United States and plans to enroll approximately three hundred (300) patients with a CAD and/or PAD diagnosis. This study does not require any study-specific tests or additional site visits.
The key goals for the Optimization Study:
1.
Assessing patient engagement within the mobile app
2.
Understanding the usefulness of the mobile app for patients
Optimization Study Eligibility Requirements
These are the key participation requirements; other eligibility participation requirements apply
- Male or female aged 40 to 90 years of age
- Have a diagnosis of coronary artery disease (CAD) and/or peripheral artery disease (PAD), and are currently on therapy or about to initiate treatment
- Have an iPhone (6s or newer, SE - any generation) or Android (released 2015 or later) device
- Have an active email account
Collaborators
Optimization Study is sponsored by Janssen Scientific Affairs, LLC. This study is done in collaboration with HCA Healthcare Research Institute.
Optimization Study is sponsored by Janssen Scientific Affairs, LLC. This study is done in collaboration with HCA Healthcare Research Institute.